Literature DB >> 11973197

Midazolam and remifentanil by bolus injection for intensely stimulating procedures of brief duration: experience with awake laryngoscopy.

Ken B Johnson1, Jeffrey D Swenson, Talmage D Egan, Robert Jarrett, Mathew Johnson.   

Abstract

IMPLICATIONS: The pharmacokinetic characteristics of midazolam and remifentanil administered by bolus injection may make them advantageous for providing brief, intense analgesia without prolonged respiratory depression. This application is particularly useful for awake, direct laryngoscopy.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 11973197     DOI： 10.1097/00000539-200205000-00035

Source DB:  PubMed          Journal:  Anesth Analg        ISSN： 0003-2999            Impact factor:   5.108


  2 in total

1.  Bolus remifentanil for chest drain removal in ICU: a randomized double-blind comparison of three modes of analgesia in post-cardiac surgical patients.

Authors:  Eoin Casey; Aoife Lane; Dinesh Kuriakose; Shane McGeary; Niamh Hayes; Dermot Phelan; Donal Buggy
Journal:  Intensive Care Med       Date:  2010-03-18       Impact factor: 17.440

2.  Evaluation of 2 ultrasonic indicators as predictors of difficult laryngoscopy in pregnant women: A prospective, double blinded study.

Authors:  Lili Xu; Shaobing Dai; Lihong Sun; Jianjun Shen; Changcheng Lv; Xinzhong Chen
Journal:  Medicine (Baltimore)       Date:  2020-01       Impact factor: 1.889
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.